NumFin

Jiang Zhong Pharmaceutical Co.,Ltd

Symbol: 600750.SS

SHH

27.05

CNY

Markedspris i dag

  • 23.0341

    P/E-forhold

  • 1.6311

    PEG Ratio

  • 16.91B

    MRK Cap

  • 0.05%

    DIV Udbytte

Jiang Zhong Pharmaceutical Co.,Ltd (600750-SS) Årsregnskaber

Download
ÅrligKvartalsvis
LineærLog
På diagrammet kan du se standardtallene i dynamik for Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS). Virksomhedens omsætning viser gennemsnittet af NaN M, som er NaN % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er NaN M, som er NaN %. Den gennemsnitlige bruttofortjeneste er NaN %. Væksten i nettoindkomst for virksomheden sidste år er NaN %, hvilket svarer til NaN % % i gennemsnit for hele virksomhedens historie.,

ÅrligKvartalsvis
10Y20Y30Y40Y

Balance

Når vi dykker ned i den skattemæssige udvikling for Jiang Zhong Pharmaceutical Co.,Ltd, ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til . Et kig tilbage på det seneste år afslører en samlet aktivændring på NaN. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til NaN i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

balance-sheet.row.cash-and-short-term-investments

01382.92744.22773.8
2080.9
1581.4
1014.6
724.8
898
250.4
605.5
711.2
957.1
537.9
748.9
264.8
130.6
112.6
69.1
83.5
44.4
117.4
190.2
266.8
240.2
155.2
30.9
59.7
122.4
4.3
2.3
4.9

balance-sheet.row.short-term-investments

0501372.81727.7
980.9
654.1
-1.1
-0.6
-0.6
-0.7
-5
-11.5
-0.9
-1.2
-1.4
0
0
0
0
0
0
0.8
0
0
10
0
0
10
0
0
0
0

balance-sheet.row.net-receivables

0562.8872.5893.1
929.3
1181.2
1005.1
895.4
530.7
789.3
1008.6
700
625.3
669.5
575.1
382.7
536.6
248.3
361.2
172.6
246.1
226.2
141.6
187.6
6.3
3
164.7
110.1
33.6
0
0
0

balance-sheet.row.inventory

0406.2382.2378
246.7
242.5
171.8
194.4
187.5
158.4
312.8
334.9
344.2
293.7
278.6
117.8
100.6
108.7
97.1
87.9
71.9
72.1
81.7
43.6
49.1
71.3
52.7
65.1
71.2
19.7
13.4
9.5

balance-sheet.row.other-current-assets

045.223.219.6
18.3
56.6
102.2
153.4
130.8
170.9
162.7
-7.4
-8.1
-58.6
-69.2
-69.9
-152.7
0.1
0.3
-16.8
0
0.4
0.7
-29.9
185.2
227
-33.5
-15.8
-2.5
0
0
0

balance-sheet.row.total-current-assets

02397.14022.14064.5
3275.2
3061.7
2293.7
1968
1747.2
1368.9
2089.6
1738.7
1918.6
1442.6
1533.5
695.3
615.1
469.8
527.7
327.2
362.4
416.1
414.2
468.2
480.8
456.5
214.8
219.1
224.8
42.9
25.9
24.3

balance-sheet.row.property-plant-equipment-net

01597.515201220.4
1021.6
1062.9
954.5
843.8
722.2
718.6
749.1
798.1
843.7
664.2
504.3
458.2
494.8
579.3
636.4
658.5
630.1
486.3
245
165.1
202.2
195.2
179.8
165.5
91.8
64.7
57.3
51.5

balance-sheet.row.goodwill

041.741.741.7
14.8
14.8
0
0
0
0
0
0
0
0
0
0
0
0
2.3
3
3.8
4.6
5.3
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0401.1379.1395.5
377.8
360
315.5
325.6
336.3
348.7
374.4
371.3
383.5
403.1
383.7
362.9
381.8
79.7
89.8
98.8
98.5
8.8
4.7
4.4
4.5
2.2
2.8
2.8
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0442.8420.8437.3
392.6
374.8
315.5
325.6
336.3
348.7
374.4
371.3
383.5
403.1
383.7
362.9
381.8
79.7
92.1
101.9
102.3
13.4
10.1
4.4
4.5
2.2
2.8
2.8
0
0
0
0

balance-sheet.row.long-term-investments

0112.9-1197.9-1568.9
-824.3
-435.8
194.1
187.2
204.1
192.6
63.1
68.7
65.8
65.4
67.5
67.9
68.2
0
0
0
0
69.1
0
0
12.8
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

060.444.444.9
39
37
26
27.2
16.4
10.4
11.7
10.4
12.1
10.8
14.6
11.7
25.6
7.5
0
0
0
1.6
0
0
-12.6
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

01517.81434.21799.4
1019.5
658.5
33.2
12.2
39.7
39.1
39.1
5.1
5.1
2.8
2.4
1.6
0.6
85.7
62.3
63.8
69.7
0.6
71.5
1.6
20.8
23.7
23.9
24.6
7.2
0
0
0

balance-sheet.row.total-non-current-assets

03731.42221.61933.1
1648.4
1697.5
1523.2
1396.1
1318.6
1309.4
1237.4
1253.7
1310.3
1146.3
972.5
902.3
971.1
752.1
790.8
824.1
802.1
570.9
326.6
171.1
227.7
221
206.4
192.9
99
64.7
57.3
51.5

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

06128.56243.75997.6
4923.6
4759.2
3817
3364.1
3065.7
2678.3
3327
2992.4
3228.9
2588.8
2506
1597.7
1586.1
1221.9
1318.6
1151.3
1164.6
986.9
740.8
639.3
708.5
677.5
421.3
412
323.8
107.6
83.2
75.8

balance-sheet.row.account-payables

0118.4236.3205.7
45.6
56.3
119.5
88.1
47.7
45.1
308.5
231.9
229.6
249.5
212.6
95.4
46.9
64
119.3
61.6
72.1
65.2
46.5
37.8
34.7
54.4
56.1
43
16.5
8.8
3.8
1.5

balance-sheet.row.short-term-debt

055.621.7
0.1
-112
20
0
30
20
125
25
200
200
225
174
364
274.1
343.1
342.4
270
125.8
59.5
22
18.1
36.3
10
10.8
10
7.2
2
3.1

balance-sheet.row.tax-payables

048.173.948.9
38.4
64.5
86.3
44.7
49.8
20.1
12.1
-55.9
11.8
4
50.4
24.3
32.7
3.2
12
10.5
3.1
31.2
-3.9
1.7
62.5
21.8
-1.2
1
3.1
3
1.7
5.2

balance-sheet.row.long-term-debt-total

011.22.8
0.2
0
50
70
0
0
498.2
496.6
525
0
0
80
0
0
0
0
127.4
36.7
0
0
13
25
53
53
53
49.3
30
30

Deferred Revenue Non Current

048.967.873
50.6
58.1
59.8
48.7
24.3
0.9
12.5
12.7
0
0
0
0
0
0
0
0
0
0
0
0
-13
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01119.91070.8809.2
386.8
692.6
227.8
241.9
224.1
155.2
125.3
81.3
100.1
119
151
77.8
125.1
18.9
65.3
7.9
10.3
38.7
5.9
3.8
3.2
15
12.8
13.8
24.9
5.1
13.1
9.6

balance-sheet.row.total-non-current-liabilities

018.590.698.6
70.8
85.9
109.8
118.7
24.4
1.1
510.9
509.3
538
12.4
3.5
83.5
2.5
0.2
0.2
0.2
127.6
65.8
26.4
0
14.1
25
53
53
53
49.3
30
30

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

011.22.8
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

01604.51748.31415.1
672.3
834.8
563.5
448.7
450
323.7
1193.9
859.1
1175.8
671.1
726.9
524.7
616.7
383.9
569.9
449.2
501.7
347.1
165.6
88.2
162.7
161.5
143.4
166.5
104.4
70.3
48.9
44.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0629.4629.6630
630
525
420
300
300
300
300
311.1
311.1
311.1
311.1
295.9
295.9
295.9
146.1
146.1
146.1
146.1
146.1
146.1
146.1
146.1
124.8
124.8
62.4
27.9
27.9
27.9

balance-sheet.row.retained-earnings

02437.32524.12652.1
2503.9
2339.6
2182.4
1893
1595.3
1335.5
1058.5
883.6
804.7
672.7
559.8
411.8
329.2
252.3
220.3
180.7
153.6
133.6
92.6
61.6
71.8
76.5
52.4
26.7
12.1
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0433.4430.1421
371
324.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0331.5307.1300
372
372
650.9
722.2
720.3
718.8
718.8
884.6
884.6
882.7
861.2
318.9
296.1
288.7
380.7
373.2
360.4
322.5
311
315.9
305.3
293.5
100.6
93.9
144.9
9.4
6.4
3.7

balance-sheet.row.total-stockholders-equity

03831.538914003
3876.9
3560.6
3253.3
2915.2
2615.5
2354.3
2077.3
2079.3
2000.4
1866.6
1732.1
1026.6
921.2
836.8
747.1
700
660.1
602.2
549.7
523.6
523.2
516.1
277.9
245.5
219.4
37.3
34.4
31.7

balance-sheet.row.total-liabilities-and-stockholders-equity

06128.56243.75997.6
4923.6
4759.2
3817
3364.1
3065.7
2678.3
3327
2992.4
3228.9
2588.8
2506
1597.7
1586.1
1221.9
1318.6
1151.3
1164.6
986.9
740.8
639.3
708.5
677.5
421.3
412
323.8
107.6
83.2
75.8

balance-sheet.row.minority-interest

0643.6604.4579.5
374.4
363.7
0.1
0.2
0.2
0.2
55.8
53.9
52.6
51.1
47
46.3
48.2
1.1
1.5
2.1
2.8
37.6
25.5
27.5
22.6
0
0
0
0
0
0
0

balance-sheet.row.total-equity

04475.14495.44582.5
4251.3
3924.4
3253.4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0162.9174.9158.8
156.6
218.3
192.9
186.6
203.4
191.9
58.1
57.2
64.9
64.2
66.1
67.9
68.2
85.7
62.3
63.8
69.3
69.9
70.8
0.1
22.8
23.7
23.8
10
0
0
0
0

balance-sheet.row.total-debt

056.63.24.5
0.3
0
20
70
30
20
623.2
521.6
725
200
225
254
364
274.1
343.1
342.4
397.4
162.5
59.5
22
31.1
61.3
63
63.8
63
56.5
32
33.1

balance-sheet.row.net-debt

0-1276.3-1368.2-1041.6
-1099.7
-927.3
-994.6
-654.8
-868
-230.4
17.7
-189.6
-232.1
-337.9
-523.9
-10.8
233.4
161.5
273.9
258.8
353
45.9
-130.7
-244.8
-199.1
-93.9
32.1
14
-59.4
52.2
29.7
28.2

Pengestrømsopgørelse

Det økonomiske landskab for Jiang Zhong Pharmaceutical Co.,Ltd har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på NaN. Virksomheden udvidede for nylig sin aktiekapital ved at udstede NaN, hvilket markerer en forskel på NaN i forhold til det foregående år. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på NaN i rapporteringsvalutaen. Dette er en forskydning på NaN fra året før. I samme periode har virksomheden registreret NaN, NaN og NaN, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på NaN, med en forskel fra år til år på NaN. Desuden afsatte virksomheden NaN til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet NaN, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

0708.3644.2530.9
490.3
479.4
470.2
417.7
379.8
368
266.8
173.5
226.9
232
261.8
199.2
129.5
96.1
75.7
52.9
43.6
62.8
38.7
47.7
31.7
37.4
33.7

cash-flows.row.depreciation-and-amortization

0122.3121.9115.4
112.8
113
72.5
62.9
65.7
67.8
83.1
93.9
76.2
67.5
70.3
64.8
59.8
60.5
63.1
58.8
42.7
24.6
21.2
15.3
12.4
15
9.5

cash-flows.row.deferred-income-tax

0-13.1-0.7-6.2
-9.6
-0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-83.110.76.2
9.6
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0161.5312.4330.2
131.7
77.3
-41.3
-353.2
256.8
24.1
-85.8
-161.6
-103.2
-120.6
-127.1
68.6
53.4
-40.1
-121.2
45.4
-96.7
-29.4
32.1
-35.7
80
-96.7
-44.7

cash-flows.row.account-receivables

0291.527.4159.5
240.6
42.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-28.1-4.3-23.6
-6.5
1.9
18.5
-3.4
-24.6
-23.9
-16.6
9.4
-50
-11.2
-164.1
-23.9
7.9
-15.1
-9.4
-20.4
-2.7
0.8
-26.9
5.1
22.8
-17.9
12.3

cash-flows.row.account-payables

0-101.8290200.5
-92.8
33.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

00-0.7-6.2
-9.6
-0.8
-59.8
-349.8
281.4
48
-69.1
-171
-53.1
-109.4
37.1
92.5
45.5
-24.9
-111.8
65.8
-94
-30.2
59
-40.8
57.2
-78.8
-57

cash-flows.row.other-non-cash-items

0182-72.6-59.5
17.8
-28.6
-15.2
-2.4
-4.3
50.8
92.7
6.1
26.5
-10.5
17.3
45.7
26.2
37.2
37.6
41.3
36.7
21
2.9
14
-2.3
22.4
-10

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-208.9-345.6-188.5
-182.5
-76.3
-121.4
-181.2
-70.1
-62.8
-102.3
-64.6
-224.4
-247.5
-140.9
-19.4
-20.5
-11.2
-30.7
-65.4
-263
-231.4
-115.4
-5.1
-27.2
-4.3
-17.5

cash-flows.row.acquisitions-net

0-13.20.11.2
183.2
131.2
0.7
1.1
2.3
14.5
0.1
0
0
0
0
0
-289
0.2
0
0
0.2
0.1
0
14.6
27.3
0
0

cash-flows.row.purchases-of-investments

0-1840.5-3260.4-5196.8
-3459
-2695.4
-13.5
-145
-105
-315.5
-160
0
-1
0
0
0
1.2
-25.9
0
0
-36.2
-0.8
-90.8
-50.1
-60
0
0

cash-flows.row.sales-maturities-of-investments

01880.23685.43949.6
2982.1
2129
72.7
119.9
152.8
215.1
3.3
0
0
0
0
21.2
13.5
0.1
1.3
0.4
0.9
0.4
0
67.2
55.5
0
13.4

cash-flows.row.other-investing-activites

000197.9
-182.5
0.1
0
48
23.4
8.6
-0.2
42.6
0.1
0
0.1
0.2
-3.9
5.6
3.4
9
0.6
1.1
1.2
-5.1
-27.2
3.8
0.1

cash-flows.row.net-cash-used-for-investing-activites

0-182.479.4-1236.6
-658.8
-511.5
-61.5
-157.2
3.4
-140.1
-259
-21.9
-225.4
-247.5
-140.7
2.1
-298.6
-31.2
-26
-56
-297.6
-230.6
-205
21.6
-31.6
-0.4
-4.1

cash-flows.row.debt-repayment

00-30-0.8
0
-70
0
-30
-20
-625
-162.3
-230
-495
-360
-354
-524
-378
-338.9
-267.3
-415
-204.2
-255.5
-132
-18.1
-36.3
-73
-0.8

cash-flows.row.common-stock-issued

002.374.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0-1.1-2.3-73.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-792.7-733.1-313.4
-163.4
-147
-135
-120.9
-123.8
-120.8
-124
-127.4
-109.5
-106.6
-101.7
-136.2
-72.5
-24.1
-44.6
-34.1
-28.6
-20
-15.9
-18.5
-3.5
-4.5
-2.6

cash-flows.row.other-financing-activites

0-9.729.4-36.1
-5.9
-70
0
10
90
20
82.8
25
1019.2
334.8
858.3
414
498.2
284
268.3
345.8
431.9
353.5
158.9
10.3
24.6
224.1
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-803.6-733.7-349.5
-163.4
-217
-135
-140.9
-53.8
-725.8
-203.4
-332.4
414.7
-131.8
402.6
-246.2
47.7
-79
-43.7
-103.3
199.1
78
11
-26.3
-15.2
146.6
-3.4

cash-flows.row.effect-of-forex-changes-on-cash

0-130.200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-38.4361.7-669
-69.7
-87.3
289.8
-173.2
647.7
-355.2
-105.7
-242.5
415.7
-211
484.1
134.2
18
43.5
-14.4
39.1
-72.2
-73.6
-99.1
36.7
74.9
124.3
-18.9

cash-flows.row.cash-at-end-of-period

01332.9550.3188.6
857.6
927.3
1014.6
724.8
898
250.4
605.5
711.2
953.6
537.9
748.9
264.8
130.6
112.6
69.1
83.5
44.4
116.6
190.2
266.8
230.2
155.2
30.9

cash-flows.row.cash-at-beginning-of-period

01371.3188.6857.6
927.3
1014.6
724.8
898
250.4
605.5
711.2
953.6
537.9
748.9
264.8
130.6
112.6
69.1
83.5
44.4
116.6
190.2
289.3
230.2
155.2
30.9
49.8

cash-flows.row.operating-cash-flow

01077.81016917
752.5
641.2
486.2
124.9
698
510.8
356.8
111.9
226.4
168.3
222.3
378.3
268.9
153.6
55.2
198.4
26.3
79
94.9
41.3
121.8
-21.9
-11.4

cash-flows.row.capital-expenditure

0-208.9-345.6-188.5
-182.5
-76.3
-121.4
-181.2
-70.1
-62.8
-102.3
-64.6
-224.4
-247.5
-140.9
-19.4
-20.5
-11.2
-30.7
-65.4
-263
-231.4
-115.4
-5.1
-27.2
-4.3
-17.5

cash-flows.row.free-cash-flow

0868.9670.3728.5
570
564.8
364.9
-56.3
628
448
254.5
47.3
2
-79.3
81.4
359
248.4
142.5
24.5
133
-236.7
-152.4
-20.5
36.2
94.5
-26.2
-28.9

Resultatopgørelse række

Jiang Zhong Pharmaceutical Co.,Ltds omsætning oplevede en ændring på NaN% sammenlignet med den foregående periode. Bruttofortjenesten for 600750.SS rapporteres til at være NaN. Virksomhedens driftsomkostninger er NaN og viser en ændring på NaN% fra sidste år. Udgifterne til afskrivninger er NaN, hvilket er en ændring på NaN% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være NaN, hvilket viser en NaN% ændring fra år til år. Salgs- og marketingomkostninger er NaN, hvilket er en ændring på NaN% sammenlignet med året før. EBITDA baseret på de seneste tal er NaN, hvilket repræsenterer en NaN% vækst i forhold til året før. Driftsindtægterne er NaN, som viser en ændring på NaN% sammenlignet med året før. Ændringen i nettoindkomsten er NaN%. Nettoindkomsten for det sidste år var NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

income-statement-row.row.total-revenue

04327.53811.62874
2441.5
2449.4
1755.2
1746.6
1561.9
2597.4
2834.1
2777.9
3191.8
2647.3
2563.6
1890
1457.6
1168.6
1181.1
979.5
834.5
941.2
667.7
355
368.5
130.1
185
218.6
231.7
338
234.8
213.8

income-statement-row.row.cost-of-revenue

01579.613401024.9
845.5
816.8
571.4
534.4
455
1286.1
1337.7
1730.9
1983.1
1760.4
1437.9
707.3
539.5
402.9
425.8
336.4
345.2
381
284.9
219.2
186.8
97.6
155.6
193.9
204.6
288.3
193.1
165.1

income-statement-row.row.gross-profit

02747.82471.61849.1
1595.9
1632.7
1183.9
1212.2
1106.9
1311.3
1496.4
1047
1208.8
886.9
1125.7
1182.7
918.1
765.7
755.2
643.1
489.2
560.2
382.7
135.7
181.7
32.5
29.4
24.7
27.1
49.7
41.7
48.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-8.9178.6126.8
100
148.7
-0.2
-10.7
-0.5
9.6
4.7
7.4
1.7
1.6
-7.4
0.6
-6.9
0.6
-8.7
-4.1
0.9
1.1
-2
-7.6
-0.1
48.5
21.3
-0.7
21.5
1.5
0
9.7

income-statement-row.row.operating-expenses

01925.41800.21288.3
1015.3
1110.5
661.7
742.4
670.8
828.9
1083.1
848.6
921.9
629
798
893.4
716.1
606.4
624.8
543.9
408.1
448
309.5
54.2
113.6
24.7
18.2
13.9
12.5
16.8
12.9
22.7

income-statement-row.row.cost-and-expenses

035053140.22313.1
1860.8
1927.3
1233
1276.8
1125.8
2115
2420.8
2579.5
2905
2389.4
2235.9
1600.7
1255.6
1009.2
1050.6
880.2
753.4
829
594.5
273.4
300.4
122.3
173.8
207.8
217.1
16.8
206
22.7

income-statement-row.row.interest-income

067.632.326.3
15.3
17
10.4
10.8
4.5
6.1
6.4
9
8.1
7.4
1.9
1.9
3.7
0
0.7
0.8
0.6
1.1
1.2
1.8
6.5
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

074.43.5
1.9
0.3
0
0.3
4.2
33
38.8
35.9
23
14
13.2
21.1
26.4
11.4
18.8
22.3
15.3
5.8
1.3
2
2.3
0.9
0.8
1
5.6
11.1
8.6
7.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

077.64.9-2.8
5.5
-1.6
25.8
2.5
7.5
-42.2
-78.9
11.2
-17.5
18.9
-24.3
-44.4
-35.2
-37.7
-31.6
-18.1
-24.9
-11.2
-4.3
-11.1
7.4
-1
2.5
20.6
15.8
-11.1
-8.6
-7.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-8.9178.6126.8
100
148.7
-0.2
-10.7
-0.5
9.6
4.7
7.4
1.7
1.6
-7.4
0.6
-6.9
0.6
-8.7
-4.1
0.9
1.1
-2
-7.6
-0.1
48.5
21.3
-0.7
21.5
1.5
0
9.7

income-statement-row.row.total-operating-expenses

077.64.9-2.8
5.5
-1.6
25.8
2.5
7.5
-42.2
-78.9
11.2
-17.5
18.9
-24.3
-44.4
-35.2
-37.7
-31.6
-18.1
-24.9
-11.2
-4.3
-11.1
7.4
-1
2.5
20.6
15.8
-11.1
-8.6
-7.3

income-statement-row.row.interest-expense

074.43.5
1.9
0.3
0
0.3
4.2
33
38.8
35.9
23
14
13.2
21.1
26.4
11.4
18.8
22.3
15.3
5.8
1.3
2
2.3
0.9
0.8
1
5.6
11.1
8.6
7.3

income-statement-row.row.depreciation-and-amortization

0122.3107.479
92.2
47.5
72.5
62.9
65.7
67.8
83.1
93.9
76.2
67.5
70.3
64.8
59.8
60.5
63.1
58.8
42.7
24.6
21.2
15.3
12.4
15
9.5
-21.1
5.6
-38.7
8.6
-41.4

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0822.5746.1626
573.9
567.6
548.2
483.1
445.7
430.6
329.9
202.3
267.8
276.9
310.8
245
173.8
121.1
111.9
80.4
59.3
104.2
71.8
77.6
75.6
49.8
36.1
31.9
9
21.9
20.1
18.7

income-statement-row.row.income-before-tax

0900.1751623.1
579.4
566
547.9
472.3
443.6
440.1
334.4
209.5
269.3
276.8
303.4
244.9
166.9
121.7
101
78.7
58.2
103.1
69.3
70.2
75.5
52.5
35.5
31.3
30.5
21.9
20.1
18.7

income-statement-row.row.income-tax-expense

0130.5106.892.2
89.1
86.6
77.7
54.6
63.8
72.1
67.7
36
42.5
44.8
41.6
45.7
37.4
25.6
25.3
25.8
14.6
40.3
30.6
22.5
43.8
15.1
1.9
5.2
4.6
7.2
6.6
-7.3

income-statement-row.row.net-income

0708.3598.2505.7
473.7
463.6
470.2
417.8
379.8
367
264.8
172.3
225.3
227.8
261.2
201.1
130.6
96.6
76.3
53.6
43.1
50.7
43.2
40.2
27.6
37.4
33.7
26.1
25.9
14.7
13.5
18.7
Lignende aktier
Du er måske også interesseret i:
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

Ofte stillede spørgsmål

Hvad er Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS) samlede aktiver?

Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS) samlede aktiver er 6128543353.000.

Hvad er virksomhedens årlige omsætning?

Den årlige omsætning er N/A.

Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er 0.650.

Hvad er virksomhedens frie pengestrøm?

Det frie cash flow er 1.431.

Hvad er virksomhedens nettoprofitmargin?

Nettofortjenstmargenen er 0.171.

Hvad er firmaets samlede omsætning?

Den samlede omsætning er 0.219.

Hvad er Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS) nettoresultat (nettoindkomst)?

Nettoresultatet (nettoindkomsten) er 708291520.000.

Hvad er virksomhedens samlede gæld?

Den samlede gæld er 56623813.000.

Hvad er tallet for driftsudgifter?

Driftsudgifterne er 1925353479.000.

Hvad er firmaets likviditet?

Virksomhedens likviditet er 0.000.